Designer Drugs: What Doctors Need to Know

This podcast episode explores the clinical pearls in the identification and management of the elusive, designer drugs.

Key Points:
- Synthetic cannabinoids are full agonists at the CB1 receptor and have weak action at the CB2 receptor.

- Suspect synthetic cannabinoid intoxication in patients presenting with red eyes, sudden development of unexplained psychosis, cognitive impairment, renal, CNS or cardiovascular problems.

- If you suspect synthetic cannabinoid intoxication, perform a full physical and neurological exam as well as routine labs, urine drug testing, ECG and possibly brain imaging.

Chapters:
00:00 Welcome
00:51 Introduction to Designer Drugs
01:40 Clinical Case Scenario
02:54 Synthetic Cannabinoids Vs Cannabis
05:59 Clinical Symptoms of Synthetic Cannabinoid Intoxication
07:41 Management of Synthetic Cannabinoid Intoxication
10:17 Treatment of Synthetic Cannabinoid Withdrawal
11:22 Designer Drugs and the DSM-5
12:52 Key Points
14:02 New Clinical Case Scenario
14:41 Closing, Credits & References

Are you a mental health clinician and want to brush up on psychopharm prescribing? We have what you need! Find the rest of Psychopharmacology Institute podcasts here:

Itunes:

Spotify:

Stitcher:

Google Podcasts:

RSS:

Website:

[jordansmith]

Possibly do a video on suboxone psychopharmacology? Like u did with buproion